Amrize Financials

Amrize Ltd

AMRZNYSE

Trade with Public

$46.29

-0.35-0.75%

At close: Aug 10, 5:00 PM EST

$46.29

N/A

After Hours: 4:00 PM EST

Earnings: Q2 2026 Earnings were released on Thu Aug 6th, after the market close

Conference Call: The most recent conference call started at 8:30 AM, 3 days ago

Click to view the webcast

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Amrize Financials

Amrize (AMRZ) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Amrize Raises FY2026 Sales Guidance from $12.290B-$12.520B to $12.500B-$12.700B vs $12.464B Est

Amrize (NYSE:AMRZ) raises FY2026 sales outlook from $12.290 billion-$12.520 billion to $12.500 billion-$12.700 billion vs $12.464 billion estimate.

Benzinga Newsdesk

PRO
Amrize Q2 Adj. EPS $0.88 Misses $0.94 Estimate, Sales $3.494B Beat $3.365B Estimate

Amrize (NYSE:AMRZ) reported quarterly earnings of $0.88 per share which missed the analyst consensus estimate of $0.94 by 6.38 percent. This is a 12.82 percent increase over earnings of $0.78 per share from the same

Benzinga Newsdesk

PRO
Amrize Affirms FY2026 Sales Guidance of $12.290B-$12.520B vs $12.420B Est

Amrize (NYSE:AMRZ) affirms FY2026 sales outlook from $12.290 billion-$12.520 billion to $12.290 billion-$12.520 billion vs $12.420 billion estimate.

Benzinga Newsdesk

PRO
Amrize Q1 Adj. EPS $(0.16) Misses $(0.13) Estimate, Sales $2.178B Beat $2.144B Estimate

Amrize (NYSE:AMRZ) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 14.29 percent decrease over losses of $(0.14) per share from the same

Benzinga Newsdesk

Earnings Scheduled For April 29, 2026

Benzinga Insights

PRO
Amrize Sees FY2026 Sales $12.290B-$12.520B vs $12.418B Est

Amrize (NYSE:AMRZ) sees FY2026 sales of $12.290 billion-$12.520 billion vs $12.418 billion analyst estimate.

Benzinga Newsdesk

Benzinga

Benzinga

Amrize Ltd

Amrize Financials

Earnings & Guidance News

PROAmrize Raises FY2026 Sales Guidance from $12.290B-$12.520B to $12.500B-$12.700B vs $12.464B Est

PROAmrize Q2 Adj. EPS $0.88 Misses $0.94 Estimate, Sales $3.494B Beat $3.365B Estimate

PROAmrize Affirms FY2026 Sales Guidance of $12.290B-$12.520B vs $12.420B Est

PROAmrize Q1 Adj. EPS $(0.16) Misses $(0.13) Estimate, Sales $2.178B Beat $2.144B Estimate

Earnings Scheduled For April 29, 2026

PROAmrize Sees FY2026 Sales $12.290B-$12.520B vs $12.418B Est

PRO
Amrize Raises FY2026 Sales Guidance from $12.290B-$12.520B to $12.500B-$12.700B vs $12.464B Est

PRO
Amrize Q2 Adj. EPS $0.88 Misses $0.94 Estimate, Sales $3.494B Beat $3.365B Estimate

PRO
Amrize Affirms FY2026 Sales Guidance of $12.290B-$12.520B vs $12.420B Est

PRO
Amrize Q1 Adj. EPS $(0.16) Misses $(0.13) Estimate, Sales $2.178B Beat $2.144B Estimate

PRO
Amrize Sees FY2026 Sales $12.290B-$12.520B vs $12.418B Est